Scientific Literature Search

Source record

Effects of a selective partial D1 agonist, CY 208-243, in de novo patients with Parkinson disease.

Emre M, Rinne UK, Rascol A, Lees A, Agid Y, Lataste X.

Mov Disord · 1992-01-01

DOI: 10.1002/mds.870070309PMID: 1535688

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's disease.

Stocchi F, Ruggieri S, Carta A, Ryatt J, Quinn N, Jenner P, Marsden CD, Agnoli A.

Mov Disord · 1992-01-01

DOI: 10.1002/mds.870070311PMID: 1620143

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Some clinical aspects of late onset parkinsonism.

Petit H, Vermersch P, Pasquier F.

Clin Neurol Neurosurg · 1992-01-01

DOI: 10.1016/0303-8467(92)90049-9PMID: 1320490

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Reliability, validity, and clinical correlates of apathy in Parkinson's disease.

Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG.

J Neuropsychiatry Clin Neurosci · 1992-01-01

DOI: 10.1176/jnp.4.2.134PMID: 1627973

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Activity and acceptability of piribedil in Parkinson's disease: a multicentre study.

Rondot P, Ziegler M.

J Neurol · 1992-01-01

DOI: 10.1007/bf00819564PMID: 1634909

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Comparison of administration of low doses of bromocriptine and levodopa in the early treatment of Parkinson disease].

Sternić N, Kostić V.

Srp Arh Celok Lek · 1992-01-01

PMID: 1641693

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Preclinical neurophysiological signs of parkinsonism in occupational manganese exposure.

Wennberg A, Hagman M, Johansson L.

Neurotoxicology · 1992-01-01

PMID: 1508430

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease.

Fahn S.

Ann Neurol · 1992-01-01

DOI: 10.1002/ana.410320722PMID: 1510371

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Neuroprotective clinical strategies for Parkinson's disease.

Shoulson I.

Ann Neurol · 1992-01-01

DOI: 10.1002/ana.410320725PMID: 1510374

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Topographic mapping of long latency "cognitive" event-related potentials (P 300): a double-blind, placebo-controlled study with amantadine in mild dementia.

Semlitsch HV, Anderer P, Saletu B.

J Neural Transm Park Dis Dement Sect · 1992-01-01

DOI: 10.1007/bf02260080PMID: 1388702

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Brain and cerebrospinal fluid cholinesterases in Alzheimer's disease, Parkinson's disease and aging. A critical review of clinical and experimental studies.

Sirviö J, Riekkinen PJ.

J Neural Transm Park Dis Dement Sect · 1992-01-01

DOI: 10.1007/bf02260081PMID: 1388703

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Clinical efficacy of Sinemet CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open, and a double-blind, double-dummy, multicenter treatment evaluation. The Dutch Sinemet CR Study Group.

Wolters EC, Horstink MW, Roos RA, Jansen EN.

Clin Neurol Neurosurg · 1992-01-01

DOI: 10.1016/0303-8467(92)90090-pPMID: 1327609

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

15.306 articles found

Effects of a selective partial D1 agonist, CY 208-243, in de novo patients with Parkinson disease.

Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's disease.

Some clinical aspects of late onset parkinsonism.

Reliability, validity, and clinical correlates of apathy in Parkinson's disease.

Activity and acceptability of piribedil in Parkinson's disease: a multicentre study.

[Comparison of administration of low doses of bromocriptine and levodopa in the early treatment of Parkinson disease].

Preclinical neurophysiological signs of parkinsonism in occupational manganese exposure.

A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease.

Neuroprotective clinical strategies for Parkinson's disease.

Topographic mapping of long latency "cognitive" event-related potentials (P 300): a double-blind, placebo-controlled study with amantadine in mild dementia.

Brain and cerebrospinal fluid cholinesterases in Alzheimer's disease, Parkinson's disease and aging. A critical review of clinical and experimental studies.

Clinical efficacy of Sinemet CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open, and a double-blind, double-dummy, multicenter treatment evaluation. The Dutch Sinemet CR Study Group.

Filters